Skip to main content
EJNMMI Research
Fig. 4 | EJNMMI Research

Fig. 4

From: 99mTc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients: a biodistribution and dosimetry study

Fig. 4

Left: Static images in a man suffering psoriatic arthritis, acquired approximately 5 h pi of 99mTc-S-HYNIC CZP. Uptake in the metacarpophalangeal, proximal and distal interphalangeal joint of the right second digit is observed, compatible with dactylitis. Right: Tracer uptake 5 h pi in both the joints and the accompanying flexor tendon in a female suffering psoriatic arthritis with clinically dactylitis of the fourth left digit

Back to article page